Advancing point-of-care diagnostics: Engineering and enhancing sensitivity and specificity in nanoparticle-based lateral flow assays for rapid disease detection

Key Points

• Enhanced sensitivity measures at 95% in nanoparticle-based lateral flow assays, indicating significant improvement.
• Assessment of assays focused on both sensitivity and specificity, showing potential in point-of-care settings.
• Engineering innovations in assay design aim to improve rapid disease detection capabilities.
• Results imply greater accuracy in clinical diagnostics, enhancing patient care and management strategies.